Back to results
CompletedEARLY_Phase 1

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

NCT02045056

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Kentucky

Lexington, Kentucky, United States

View on ClinicalTrials.gov
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease — TrialFind